BioCheck
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
CanadaWebsite
www.biochecklabs.comRevenue
<$5 MillionIndustry
About BioCheck
BioCheck Org Chart
Is BioCheck your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on BioCheck recently announced quarterly report
Check if BioCheck has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when BioCheck launches new products
Congratulate Masked Content for being promoted to Masked Content at BioCheck
Funding: Get notified immidiatlly once BioCheck has new funding data
Click to see if BioCheck had a recent Job posting/layoffs
Check out if BioCheck is spiking on competitors!
Website visits: Recent activity has been detected on your website
BioCheck, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
BioCheck is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioCheck is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioCheck.
BioCheck Tech Stack
A closer look at the technologies used by BioCheck
BioCheck News & Media
Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Antibody Testing System
TUCSON, Ariz., Aug. 18, 2020 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) and BioCheck, Inc., a privately-held San Francisco-based company focused on in vitro diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use...Accelerate Diagnostics and BioCheck Announce Commercial Supply and Collaboration Agreement to Distribute MS-FAST Chemiluminescence Immunoassay Analyzer and SARS-CoV-2 Antibody Tests
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) and BioCheck, Inc., a privately-held San Francisco-based company focused on in vitro diagnostics, today announced that they have entered into a commercial supply and collaboration agreement. Under the agreement, Accelerate Diagnostics will distribute the BioCheck MS-FAST, a fully-automated chemiluminescence immunoassay analyzer, along with BioCheck's SARS-CoV-2 tests for the detection of IgG and IgM antibodies. The agreement covers North America, Europe
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding BioCheck
Since 1997, BioCheck, Inc. has been engaged in the development and manufacturing of high-quality in vitro diagnostic test kits for the worldwide biomedical, pharmaceutical, and scientific research markets under cGMP and ISO 13485 standards. BioCheck is commercializing the (automated chemiluminescent platform (ACL-Platform)) and associated Covid-19... Read More